214 related articles for article (PubMed ID: 32827811)
1. Actinomyces and MRONJ: A retrospective study and a literature review.
Cerrato A; Zanette G; Boccuto M; Angelini A; Valente M; Bacci C
J Stomatol Oral Maxillofac Surg; 2021 Nov; 122(5):499-504. PubMed ID: 32827811
[TBL] [Abstract][Full Text] [Related]
2. CT imaging features of antiresorptive agent-related osteonecrosis of the jaw/medication-related osteonecrosis of the jaw.
Baba A; Goto TK; Ojiri H; Takagiwa M; Hiraga C; Okamura M; Hasegawa S; Okuyama Y; Ogino N; Yamauchi H; Kobashi Y; Yamazoe S; Munetomo Y; Mogami T; Nomura T
Dentomaxillofac Radiol; 2018 May; 47(4):20170323. PubMed ID: 29365278
[TBL] [Abstract][Full Text] [Related]
3. Medication-related osteonecrosis of the jaw: risk factors in patients under biphosphonate versus patients under antiresorptive-antiangiogenic drugs.
Ghidini G; Manfredi M; Giovannacci I; Mergoni G; Sarraj A; Mureddu M; Giunta G; Bonanini M; Meleti M; Vescovi P
Minerva Stomatol; 2017 Aug; 66(4):135-140. PubMed ID: 28497661
[TBL] [Abstract][Full Text] [Related]
4. Microbial diversity in infections of patients with medication-related osteonecrosis of the jaw.
Zirk M; Wenzel C; Buller J; Zöller JE; Zinser M; Peters F
Clin Oral Investig; 2019 May; 23(5):2143-2151. PubMed ID: 30276516
[TBL] [Abstract][Full Text] [Related]
5. A systematic review of metastatic cancer presenting in osteonecrosis of the jaws (MC-ONJ) in patients undergoing antiresorptive and/or antiangiogenic therapy for skeletal-related adverse events.
Sacco R; Woolley J; Yates J; Calasans-Maia MD; Akintola O; Patel V
Oral Surg Oral Med Oral Pathol Oral Radiol; 2021 Jun; 131(6):650-659. PubMed ID: 33518491
[TBL] [Abstract][Full Text] [Related]
6. Targeted histological evaluation shows high incidence of actinomyces infection in medication-related osteonecrosis of the jaws.
Brody A; Scheich B; Dobo-Nagy C
Sci Rep; 2022 Mar; 12(1):3406. PubMed ID: 35233034
[TBL] [Abstract][Full Text] [Related]
7. Medication-related osteonecrosis of the jaw-like lesions in rodents: A comprehensive systematic review and meta-analysis.
Kuroshima S; Sasaki M; Murata H; Sawase T
Gerodontology; 2019 Dec; 36(4):313-324. PubMed ID: 31373407
[TBL] [Abstract][Full Text] [Related]
8. Emerging therapies with potential risks of medicine-related osteonecrosis of the jaw: a review of the literature.
Kanwar N; Bakr MM; Meer M; Siddiqi A
Br Dent J; 2020 Jun; 228(11):886-892. PubMed ID: 32541753
[TBL] [Abstract][Full Text] [Related]
9. Infection as an Important Factor in Medication-Related Osteonecrosis of the Jaw (MRONJ).
Otto S; Aljohani S; Fliefel R; Ecke S; Ristow O; Burian E; Troeltzsch M; Pautke C; Ehrenfeld M
Medicina (Kaunas); 2021 May; 57(5):. PubMed ID: 34065104
[TBL] [Abstract][Full Text] [Related]
10. The association of medication-related osteonecrosis of the jaw with Actinomyces spp. infection.
Russmueller G; Seemann R; Weiss K; Stadler V; Speiss M; Perisanidis C; Fuereder T; Willinger B; Sulzbacher I; Steininger C
Sci Rep; 2016 Aug; 6():31604. PubMed ID: 27530150
[TBL] [Abstract][Full Text] [Related]
11. Dental implants as risk factors for patients with medication-related osteonecrosis of the jaws (MRONJ).
Pichardo SEC; van der Hee JG; Fiocco M; Appelman-Dijkstra NM; van Merkesteyn JPR
Br J Oral Maxillofac Surg; 2020 Sep; 58(7):771-776. PubMed ID: 32631756
[TBL] [Abstract][Full Text] [Related]
12. Clinical considerations for medication-related osteonecrosis of the jaw: a comprehensive literature review.
Kawahara M; Kuroshima S; Sawase T
Int J Implant Dent; 2021 May; 7(1):47. PubMed ID: 33987769
[TBL] [Abstract][Full Text] [Related]
13. Role of microbiological culture and polymerase chain reaction (PCR) of actinomyces in medication-related osteonecrosis of the jaw (MRONJ).
Panya S; Fliefel R; Probst F; Tröltzsch M; Ehrenfeld M; Schubert S; Otto S
J Craniomaxillofac Surg; 2017 Mar; 45(3):357-363. PubMed ID: 28162845
[TBL] [Abstract][Full Text] [Related]
14. Is the prevalence of the medication-related osteonecrosis of the jaws underestimated, evaluation in oncological and non-oncological disease.
Galis B; Zajko J; Hirjak D; Vanko L; Kupcova I; Jurkemik J; Gengelova P; Mikuskova K; Halmova K; Riznic M; Czako L
Bratisl Lek Listy; 2017; 118(12):724-731. PubMed ID: 29322803
[TBL] [Abstract][Full Text] [Related]
15. Surgical therapy for medication-related osteonecrosis of the jaw in osteoporotic patients treated with antiresorptive agents.
Hauer L; Jambura J; Hrusak D; Chalupova M; Posta P; Rusnak S; Vyskocil V
Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub; 2020 Mar; 164(1):100-107. PubMed ID: 30647474
[TBL] [Abstract][Full Text] [Related]
16. The Prevention of Medication-related Osteonecrosis of the Jaw.
Poxleitner P; Engelhardt M; Schmelzeisen R; Voss P
Dtsch Arztebl Int; 2017 Feb; 114(5):63-69. PubMed ID: 28241916
[TBL] [Abstract][Full Text] [Related]
17. Denosumab-related osteonecrosis of the jaw: a report of 2 cases and review of the literature.
Chehal H; Nikitakis NG; Islam MN; Goodchild JH; Mordini L; Bhattacharyya I
Gen Dent; 2019; 67(1):42-46. PubMed ID: 30644830
[TBL] [Abstract][Full Text] [Related]
18. Association Between Malignant Diseases and Medication-Related Osteonecrosis of the Jaw (MRONJ): A Systematic Review and Meta-Analysis.
Yao S; Ding X; Rong G; Zhou J; Zhang B
J Craniofac Surg; 2023 Mar-Apr 01; 34(2):669-673. PubMed ID: 36184756
[TBL] [Abstract][Full Text] [Related]
19. Medication-related osteonecrosis of the jaw: An update on the memorial sloan kettering cancer center experience and the role of premedication dental evaluation in prevention.
Owosho AA; Liang STY; Sax AZ; Wu K; Yom SK; Huryn JM; Estilo CL
Oral Surg Oral Med Oral Pathol Oral Radiol; 2018 May; 125(5):440-445. PubMed ID: 29580668
[TBL] [Abstract][Full Text] [Related]
20. Medication-related osteonecrosis of the jaw: knowledge and perceptions of medical professionals on the usage of bone modifying agents and dental referrals.
Acharya S; Patil V; Ravindranath V; Kudva A; Nikhil K
J Med Life; 2022 Mar; 15(3):368-373. PubMed ID: 35449990
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
